Lv1
30 积分 2025-11-05 加入
Not All HER2-Positive Breast Cancers Are the Same: Intratumoral Heterogeneity, Low-Level HER2 Amplification, and Their Impact on Neoadjuvant Therapy Response
15天前
已关闭
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO–College of American Pathologists Guideline Update
15天前
已完结
Sclerosing polycystic adenoma – A review
5个月前
已关闭
Intercalated Duct Lesions of Salivary Gland: A Morphologic Spectrum From Hyperplasia to Adenoma
5个月前
已完结
The association between type of endocrine therapy and development of estrogen receptor-1 mutation(s) in patients with hormone-sensitive advanced breast cancer: A systematic review and meta-analysis of randomized and non-randomized trials
5个月前
已完结
Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells
6个月前
已完结
MAPK signaling mediates tamoxifen resistance in estrogen receptor-positive breast cancer
8个月前
已完结
Resistance to CDK4/6 inhibition: Mechanisms and strategies to overcome a therapeutic problem in the treatment of hormone receptor-positive metastatic breast cancer
8个月前
已完结
Addition of PI3K/AKT/mTOR inhibitors to fulvestrant for advanced HR+/HER2- breast cancer: a systematic review and meta-analysis
8个月前
已完结
p70 S6 kinase as a therapeutic target in cancers: More than just an mTOR effector
8个月前
已完结
皖公网安备34019202002308
